- 26% of metastatic patients were misdiagnosed
- Helps people with a stealthy form of breast cancer
- Not a new treatment — but a wake-up call for doctors
This survey reveals how often a hidden form of breast cancer is missed — delaying care.
She went to the doctor with stomach pain. They said it was indigestion. Then a hernia. Then stress.
But after a year of worsening symptoms, scans found cancer — not in her stomach, but in her breast tissue. It had spread silently for years.
This is not rare. It’s happening to thousands.
Invasive lobular breast cancer (ILC) is a quieter, sneakier form of breast cancer. It doesn’t always form a lump. It doesn’t always show up on mammograms.
ILC makes up about 10–15% of all breast cancers. That’s around 40,000 cases a year in the U.S. alone.
When it spreads — called metastatic ILC, or mILC — it often goes to unusual places. The belly lining. The gut. The ovaries. Even the eye.
And because symptoms like bloating or back pain are common, doctors may not think “cancer.”
Many patients are treated for other conditions first — like irritable bowel syndrome or menopause.
But the real problem? The delay.
Some wait over a year for the right diagnosis. That’s time when treatment could have started.
The Misdiagnosis Trap
For years, doctors assumed breast cancer spread in predictable ways — mostly to bones, lungs, liver, or brain.
And most types do.
But ILC plays by different rules.
It spreads in thin strands, like spiderwebs, making it harder to spot on scans.
Worse, it often doesn’t light up on standard PET scans that rely on glucose uptake (FDG-PET).
So even when doctors look, they may not see it.
But here’s the twist: patients often feel something is wrong — long before scans confirm it.
Fatigue. Bloating. Belly pain. Weight loss.
Yet without clear imaging, many are told, “It’s probably nothing.”
What Patients Are Saying
A new survey of 321 people with metastatic ILC found something alarming.
One in four — 26.2% — were misdiagnosed at first.
That’s 84 people who were told they had something else.
The most common wrong diagnoses?
Back problems. Benign breast changes. Even menopause.
Some were sent to orthopedists for “bone pain” that was actually cancer spread.
Others had gastric surgeries — only to later learn they had breast cancer.
And 31% of those misdiagnosed had two or more wrong diagnoses before the truth.
This doesn’t mean this treatment is available yet.
The Long Wait for Answers
Nearly half of patients — 44.5% — waited more than a year to get the right diagnosis.
Even with mammograms.
Here’s the shock: 40% of patients had a mammogram around the time of their misdiagnosis.
But ILC was found in only 1 in 5 of those scans.
Why? Because ILC doesn’t always form a dense lump. It grows in single-file lines of cells — like scattered seeds — that standard imaging can miss.
Even more concerning: when cancer is already widespread at first diagnosis (called de novo metastatic), mammograms caught it in just 1 out of 4 cases.
That means three out of four were missed — until symptoms forced further testing.
Patients often need ultrasounds, MRIs, or biopsies to confirm ILC.
But if doctors don’t suspect it, those tests don’t happen.
The survey found three main reasons for delays:
1. Imaging wasn’t clear 2. Doctors didn’t know about ILC’s unusual spread 3. Patients were misdiagnosed first
And in some cases, the wrong diagnosis led to the wrong treatment.
Six patients got chemotherapy for a different type of cancer — not their real one.
Forty-nine were treated for non-cancer conditions like hernias or IBS — delaying real care.
The Hidden Symptoms
Not all cancer symptoms scream for attention.
In this study, 43% of patients reported symptoms before diagnosis.
The most common?
Back pain. Fatigue. Stomach issues. Bloating. Weight loss.
These aren’t dramatic signs. They’re easy to brush off.
But when they linger — especially after breast cancer — they may be clues.
One patient said she was told her bloating was “just aging.” It turned out to be cancer in her abdomen.
Another had repeated “menopause” explanations for fatigue and weight loss. It was actually metastatic disease.
What Scientists Didn’t Expect
You’d think regular check-ups would catch recurrence faster.
But here’s the surprise: patients under active surveillance after early-stage ILC were no faster to get diagnosed when it spread.
That means even with routine scans and doctor visits, mILC slipped through.
Why? Because standard follow-up doesn’t always include the right tests for ILC’s favorite hiding spots — like the belly or gut.
So patients feel sick — but their “normal” scans come back clear.
If you or a loved one had lobular breast cancer, this matters.
It means trusting your gut — literally and figuratively.
If symptoms don’t make sense — if they’re dismissed — speak up.
Ask: Could this be ILC?
Push for more testing: MRI, ultrasound, or biopsy — not just mammograms.
And consider sharing this survey data with your care team.
It’s not a new drug. It’s not a cure.
But it’s proof that the system is missing something critical.
The Bigger Picture
Experts say this study is a red flag — not just for oncologists, but for all doctors.
When a patient with a history of breast cancer comes in with belly pain or bloating, ILC should be on the list.
Even if mammograms are “clear.”
Even if years have passed.
Because ILC can return a decade later — quietly, invisibly.
Raising awareness may be the fastest way to improve outcomes — faster than waiting for better scans or drugs.
This study didn’t test a new treatment. It listened to patients.
And what they said should change how doctors think.
Next steps? More education. Better screening tools. And trials to test smarter imaging for ILC.
But for now — awareness is the most powerful tool we have.
